Divergent molecular strategies drive evolutionary adaptation to competitive fitness in biofilm formation.

Zhijian Yu, Zhao Cai, Ruixue Yang, Shuo Li, Qiong Yang, Liang Yang, Peiyu Li, Mingxing Tang, Zilin Zhuang, Shuhong Han, Yunke Sun, Kewei Fan

Journal: The ISME journal 2024;18(1):

PMID: 39052320

Abstract

Biofilm is a group of heterogeneously structured and densely packed bacteria with limited access to nutrients and oxygen. These intrinsic features can allow a mono-species biofilm to diversify into polymorphic subpopulations, determining the overall community's adaptive capability to changing ecological niches. However, the specific biological functions underlying biofilm diversification and fitness adaptation are poorly demonstrated. Here, we launched and monitored the experimental evolution of Pseudomonas aeruginosa biofilms, finding that two divergent molecular trajectories were adopted for adaptation to higher competitive fitness in biofilm formation: one involved hijacking bacteriophage superinfection to aggressively inhibit kin competitors, whereas the other induced a subtle change in cyclic dimeric guanosine monophosphate signaling to gain a positional advantage via enhanced early biofilm adhesion. Bioinformatics analyses implicated that similar evolutionary strategies were prevalent among clinical P. aeruginosa strains, indicative of parallelism between natural and experimental evolution. Divergence in the molecular bases illustrated the adaptive values of genomic plasticity for gaining competitive fitness in biofilm formation. Finally, we demonstrated that these fitness-adaptive mutations reduced bacterial virulence. Our findings revealed how the mutations intrinsically generated from the biofilm environment influence the evolution of P. aeruginosa.

© The Author(s) 2024. Published by Oxford University Press on behalf of the International Society for Microbial Ecology.

Address: Department of Otorhinolaryngology, Shenzhen Nanshan People's Hospital, Shenzhen 518052, China.; Community Health Service Center of Southern University of Science and Technology, Nanshan Medical Group Headquarters, Shenzhen 518055, China.; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.; Department of Infectious Diseases, Shenzhen Nanshan People's Hospital, Shenzhen University School of Medicine, Shenzhen 518052, China.; Department of Research and Development, Shenzhen Mindray Bio-Medical Electronics Co, Ltd, Shenzhen 518057, China.; Department of Otorhinolaryngology, Shenzhen Nanshan People's Hospital, Shenzhen 518052, China.; Allergy Prevention and Control Center, Nanshan People's Hospital, Shenzhen 518052, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.